SCHEMBL24920949

SCHEMBL24920949

COCCCCCCCCN1CCN(C)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
PAOX Q6QHF9 1/20 0.50
USP2 O75604 1/20 0.50
HPGD P15428 1/20 0.50
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
RAB9A P51151 1/20 0.43
HRH3 Q9Y5N1 2/20 0.41
CSNK2A2 P19784 1/20 0.41
CSNK2B P67870 1/20 0.41
CSNK2A1 P68400 1/20 0.41
CSNK2A3 Q8NEV1 1/20 0.41
ABCB1 P08183 1/20 0.40
DRD3 P35462 1/20 0.40
POLB P06746 1/20 0.40
RAD52 P43351 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23158354 1.00 ALDH1A1 (0.50) ALDH1A1PAOXUSP2HPGDMEN1
SCHEMBL20234238 1.00 ALDH1A1 (0.50) ALDH1A1PAOXUSP2HPGDMEN1
SCHEMBL20231214 1.00 ALDH1A1 (0.50) ALDH1A1PAOXUSP2HPGDMEN1
SCHEMBL10305196 0.98 ALDH1A1 (0.51) ALDH1A1PAOXUSP2HPGDMEN1
SCHEMBL24920416 0.94 ALDH1A1 (0.46) ALDH1A1PAOXUSP2HPGDMEN1
SCHEMBL11570576 0.93 HRH3 (0.46) ALDH1A1PAOXUSP2HPGDHRH3
SCHEMBL11569007 0.93 HRH3 (0.46) ALDH1A1PAOXUSP2HPGDHRH3
SCHEMBL10927336 0.93 HRH3 (0.46) ALDH1A1PAOXUSP2HPGDHRH3
SCHEMBL11573327 0.93 HRH3 (0.46) ALDH1A1PAOXUSP2HPGDHRH3
SCHEMBL27365597 0.92 ALDH1A1 (0.45) ALDH1A1PAOXUSP2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed